SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J.B. Chemicals & Pharmaceuticals informs about postal ballot notice

21 Feb 2026 Evaluate

J.B. Chemicals & Pharmaceuticals has informed that it enclosed the Postal Ballot Notice sent to the members of the Company today seeking their assent or dissent by remote e-voting on the Ordinary Resolutions pertaining to (i) Appointment of Aman Mehta (DIN: 08174906) as a Director of the Company, (ii) Appointment of Aman Mehta (DIN: 08174906) as Managing Director of the Company; (iii) Appointment of Amal Kelshikar (DIN: 06378987) as a Non?Executive Non-Independent Director of the Company; (iv) Appointment of Hasmukh Patel (DIN: 11486584) as a Non-Executive Non-Independent Director of the Company; and (v) appointment of Sudhir Menon (DIN: 09502215) as a Non?Executive Non-Independent Director of the Company. The Company has sent the said Postal Ballot Notice accompanied by an explanatory statement through e-mail on February 20, 2026 to those members of the Company who had registered their e-mail address with the Company or depository participant/depository as on February 13, 2026 (‘cut-off date’). The remote e-voting through e-voting platform of National Securities Depository shall commence on Sunday, February 22, 2026 at 9.00 am (IST) and end on Monday, March 23, 2026 at 5.00 pm (IST). The result of the postal ballot will be declared on or before Wednesday, March 25, 2026.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

1998.65 -5.10 (-0.25%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×